CPT 89257: Identification of Sperm from Non-Seminal Aspirates
Commercial payers pay $153 on average nationally for this procedure.
CPT code 89257 describes laboratory identification of sperm cells obtained by aspiration from sources other than seminal fluid or semen, a diagnostic laboratory service used in reproductive and male infertility evaluations; service type: laboratory identification/diagnostic sperm identification; typical site of service: clinical laboratory or hospital laboratory performing and reporting sperm identification from aspirated specimens.
For related coverage guidance, see recent payer policy updates: Prenatal (Fetal) Diagnostic Testing, Oral Cancer Screening and Testing, RTM Testing for Alpha-1 Antitrypsin Deficiency.
Customize your policy alerts
Sign up for cpt 89257 policy alerts
Get alerted when payer policies referencing 89257 are released or updated.
Monitor payer policy activity
National Reimbursement Benchmarks
For CPT 89257, the BUCA average commercial rate sits at $152.80, offering a mid-market reference point against individual payer distributions. Blue Cross Blue Shield and Aetna present wide dispersion, with interquartile ranges of $149.50 (BCBS P75 $240.70 minus P25 $109.20) and $164.80 (Aetna P75 $315.00 minus P25 $150.20) respectively, indicating substantial variability in contracted rates. UnitedHealth Group and Cigna show much tighter spreads: UnitedHealth Group’s IQR is $6.40 (P75 $63.30 minus P25 $59.90) and Cigna’s IQR is $1.10 (P75 $3.70 minus P25 $2.60), reflecting more consistent pricing among their networks.
Looking at central tendency, Aetna’s mean of $221.80 sits above the BUCA average, while Blue Cross Blue Shield’s mean of $191.20 is also above BUCA. UnitedHealth Group’s mean of $60.70 and Cigna’s mean of $22.70 fall below the BUCA average, illustrating a bimodal market: a cluster of higher means (Aetna, Blue Cross Blue Shield) and a cluster of lower means (UnitedHealth Group, Cigna). BUCA’s average is useful as a commercial midpoint but does not capture the wide payer-by-payer variability highlighted by the interquartile comparisons.